课题基金 / 基金详情

Technologies and Resources for Core Laboratories

Technologies and Resources for Core Laboratories
核心实验室的技术和资源
批准号:
10685612
负责人:
Laura F. Gibson
金额:
$17.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-08-15 至 2027-06-30

项目摘要

项目成果

Laura F. Gibson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Technology and Resources for Core Laboratories Core (Technology Core) of the West Virginia Clinical and Translational Science Institute (WVCTSI) supports research infrastructure critical for rapid translation of innovation to positively impact the health of West Virginians. Importantly, the Technology Core leverages the significant previous IDeA investment in West Virginia, while bringing exciting innovation to support clinical and translational (C/T) investigators’ efforts. Resources described in this Core are essential in providing infrastructure to engage and train C/T scientists with a focus on essential pipeline development as well as diversity of the future generation of C/T investigators. The Technology Core will leverage a strong statewide infrastructure through partnerships with West Virginia University (WVU), Marshall University (MU), NIOSH and the WV DHHR that has been strengthened during the previous funding period. New technical capacity will be provided to investigators and their trainees to support interrogation of current, acute, problems as well as being positioned to take on emerging and future public health crises. The capacity to be nimble in the scope and focus of research that can be supported, both technically and intellectually, is central to the Core. The specific aims that will operationalize our progress towards these goals include to: (1) develop and optimize molecular and protein-based diagnostic assays and support lead compound optimization via an automated pipeline in the newly established Molecular Medicine Laboratory (MML), (2) enable investigations of the health effects of inhalation exposures relevant to rural communities via the state of the art inhalation toxicology facility (iTox) and (3) support translational investigations of pathogens underlying emerging infectious diseases. Focus across the Technology Core is provided by tethering all activities to WVCTSI priority health areas to avoid diffusion of investment and energy, and maximize investment to achieve significant and measurable outcomes. Relevance is obtained by absolute diligence in the design and focus of each aim connecting to a clinical application. In combination, this results in impact on our understanding of specific diseases of interest, and the potential to impact positively on the health of West Virginians while contributing to the broader scientific community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Technologies and Resources for Core Laboratories
  • 批准号:
    10505670
  • 项目类别:
  • 资助金额:
    $38.77万
  • 财政年份:
    2012
  • 负责人:
    Laura F. Gibson
  • 依托单位:
Technologies and Resources for Core Laboratories
  • 批准号:
    10213758
  • 项目类别:
  • 资助金额:
    $43.32万
  • 财政年份:
    2012
  • 负责人:
    Laura F. Gibson
  • 依托单位:
CoBRE for Signal Transduction and Cancer Phase III
  • 批准号:
    8116200
  • 项目类别:
  • 资助金额:
    $111.0万
  • 财政年份:
    2011
  • 负责人:
    Laura F. Gibson
  • 依托单位:
CoBRE for Signal Transduction and Cancer Phase III
  • 批准号:
    8299627
  • 项目类别:
  • 资助金额:
    $111.0万
  • 财政年份:
    2011
  • 负责人:
    Laura F. Gibson
  • 依托单位:
海外基金